Atlas Trials

Safety, Tolerability and Efficacy of Sofosbuvir, Velpatasvir, and Voxilaprevir in Subjects With Previous DAA Experience

Clinical trial NCT02745535 · COMPLETED

Trial details

NCT number
NCT02745535
Sponsor
University of Maryland, Baltimore
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Chronic Hepatitis C
Start date
2016-05-01
Primary completion
2018-10-24
Enrollment
77

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.